1. Contemporary Practice of Anemia Treatment Among Dialysis Patients in the United States
- Author
-
Eric D. Weinhandl, William Eggert, Yunji Hwang, David T. Gilbertson, and Jeffrey Petersen
- Subjects
anemia ,erythropoiesis-stimulating agent ,hemodialysis ,hemoglobin ,Diseases of the genitourinary system. Urology ,RC870-923 - Abstract
Introduction: The treatment of anemia is a major activity in the care of patients undergoing maintenance hemodialysis (HD). The comparative effectiveness of new pharmacologic treatments, relative to erythropoiesis-stimulating agents (ESAs), should be anticipated on the bases of controlled trials and current practice. We describe the contemporary practice of anemia treatment in a national cohort of patients undergoing maintenance HD. Methods: We analyzed the United States Renal Data System (USRDS) data to identify adult patients undergoing in-facility HD in 2016 to 2019. Using the Consolidated Renal Operations in a Web-Enabled Network (CROWNWeb) dataset, we identified hemoglobin and ESA utilization (agent and cumulative dose) during each patient-month, as well as intravenous (IV) iron utilization, ferritin, and transferrin saturation. We compared ESA dosing during the study era to dosing in the Normal Hematocrit Cardiac Trial (NHCT), conducted in the 1990s. We assessed ESA hyporesponsiveness by estimating the prevalence of the following: (i) high erythropoietin resistance index (ERI) and (ii) either 3 or 6 consecutive months with hemoglobin
- Published
- 2023
- Full Text
- View/download PDF